TickerFactsScreenerDevelopers

BridgeBio Pharma, Inc. (BBIO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2017: $92.00M2018: $436.09M2019: $363.77M2020: $356.08M2021: $393.77M2022: $376.69M2023: $375.94M2024: $681.10M2025: $570.12M$570.12M
2017Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$570.12M-16.3%
2024$681.10M+81.2%
2023$375.94M-0.2%
2022$376.69M-4.3%
2021$393.77M+10.6%
2020$356.08M-2.1%
2019$363.77M-16.6%
2018$436.09M+374.0%
2017$92.00M—